RevivBio
PrivateLast Round
Grant
Sep 1, 2024
Total Funding Raised
$3.63M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
RevivBio operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Grant round in September 2024.
RevivBio is a biotechnology company that operates a bioengineering and data-driven molecular design platform to develop functional biologics for crop, human, and animal health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Water Treatment
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RevivBio Comparables
Compare RevivBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arzeda | 75% | |
| Adaptyv Bio | 74% | |
| Basecamp Research | 73% |
For institutional investors. Book with your work email.
RevivBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2024 | ||||
| Accelerator | Apr 2, 2024 | ||||
| Seed | Jan 16, 2024 | ||||
| Accelerator | May 5, 2023 | ||||
| Debt | Jul 5, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
RevivBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| gener8tor | Seed |
| BioGenerator Ventures | Debt, Seed |
| The Elizabeth Elting Venture Fund | Accelerator |
| Intel Ignite | Accelerator |
| Tet Ventures | Seed |
| Endless Frontier Labs | Accelerator |
| Alumni Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 36% MoM, reaching 2.9K.
- Jul 29, 2026
Monthly visitors increased 155% MoM, reaching 1.7K.
For institutional investors. Book with your work email.
RevivBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RevivBio's valuation, stock price, and market status.
Is RevivBio a public or private company?
RevivBio is a private company.
What is the current stock price of RevivBio?
RevivBio is a private company, so its shares have no public market price. Caplight tracks RevivBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RevivBio worth (valuation)?
Valuation information for RevivBio is not publicly available.
Can I buy RevivBio stock?
RevivBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RevivBio's last funding round?
RevivBio's most recent funding round was Grant on September 1, 2024.
Who are the main investors in RevivBio?
Key investors in RevivBio include Intel Ignite, National Science Foundation.
Will RevivBio IPO soon?
No public IPO plans have been announced for RevivBio.
How can I track RevivBio secondary market activity?
Caplight tracks bids, offers, and trades in RevivBio's shares on secondary markets.